Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immunoassay for F1.2 prothrombin fragment

a technology of prothrombin and immunoassay, which is applied in the field of immunoassay for f1.2 prothrombin fragment, can solve the problems of difficult quantification of f1.2 in plasma, and achieve the effect of convenient attachment poin

Inactive Publication Date: 2003-11-27
RUIZ JUAN A +1
View PDF8 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This cross-reactivity and the low concentration of F1.2 have made the quantitation of F1.2 in plasma difficult.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immunoassay for F1.2 prothrombin fragment
  • Immunoassay for F1.2 prothrombin fragment
  • Immunoassay for F1.2 prothrombin fragment

Examples

Experimental program
Comparison scheme
Effect test

example 1b

Monoclonal Antibody CC1-5D

[0064] Monoclonal CC1-5d was derived from mice immunized with fragment F1.2. Mouse serum titration, cell fusion, hybridoma selection, ascites production and characterization were performed essentially as described in sections E through M above.

[0065] A. Affinity Data

[0066] The affinity constant for this monoclonal antibody was determined to be 7.04.times.10.sup.8 L / M. This constant was obtained using the method described in Friguet et al., Measurements of the True Affinity of Antigen-Antibody Complexes by Enzyme-Linked Immunoadsorbent Assay, 77, J. Immunol. Methods 305 (1985).

example 2

Rabbit Polyclonal Antibodies

[0067] A. Rabbit Polyclonal Antibody Preparation

[0068] Peptides were synthesized according to the procedure disclosed in Example 1A, Section A. Ovalbumin conjugates with peptide C700H were made according to Example 1A, Section C.

[0069] B. Rabbit Immunization Schedule

[0070] Rabbits were immunized by a series of sub Q injections in either Complete or Incomplete Freund's Adjuvant. Immunization spanned 38 days; at the end of this period, antiserum titers were checked.

[0071] Antisera from rabbits AB51-AB55 were tested serially at dilutions between 1:1000 to 1:64,000. Antibody dilutions were incubated for one hour at room temperature on microtiter plates coated with a variety of synthetic peptides or F1.2. The wells were washed three times with PBS containing 0.05% Tween 20 and incubated with goat anti-rabbit immunoglobulin / peroxidase for 1 hour. The wells were again washed three times as before and peroxidase was added for 15-30 minutes.

[0072] Rabbit antisera ...

example 3

Sandwich Assay Using Monoclonal Antibodies

[0073] Monoclonal TA1-5e is immobilized on a solid carrier, such as in microtiter wells. A sample of patient plasma containing F1.2 and other plasma proteins is then contacted with immobilized TA1-5e for a specified time and temperature (i.e. 2 hours at room temperature). At this stage insoluble complex is formed between immobilized TA1-5e and F1.2; any unreacted F1.2 is removed by washing the microwell.

[0074] A measured amount of monoclonal CC1-5d Fab fragment, covalently labelled with an enzyme such as alkaline phosphatase, is then added to the above insoluble complex and incubated for a specified time and temperature (i.e. 1 hour at room temperature). The unreacted portion of labelled CC1-5d is again removed by washing. The amount of bound, labelled antibody is determined using an alkaline phosphatase substrate, such as 4-methyl-umbelliferyll-phosphate.

[0075] The amount of bound, labelled antibody is directly proportional to the concentra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

According to the present invention highly specific-low affinity antibodies are generated which allow for the assay of F1.2 in bodily fluids that also contain prothrombin or other plasma proteins. Antibodies having the necessary properties for this assay are made using synthetic polypeptides which mimic the carboxy terminus of F1.2.

Description

BACKGROUND OF INVENTION[0001] This invention relates to chemically synthesized immunogens which generate antibodies specific for the activation peptide from prothrombin, F1.2. In Another aspect, it relates to methods for detecting the presence and / or concentration of F1.2 in plasma.[0002] Many proteins are synthesized in vivo as inactive precursors, or zymogens, which are subsequently converted to their active forms by limited proteolysis. This process of zymogen activation is a rate-limiting step in a variety of physiological processes which include blood coagulation. Blood coagulation proteins are "activated" by highly specific, limited peptide bond cleavage, which generate new carboxy and amino termini. The amino acid sequence within these termini is highly specific for a particular coagulation protein. These termini which are often located at the surface of the protein, show a relatively high conformational flexibility and are frequently good antigenic determinants.[0003] Prothr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/86
CPCG01N33/86
Inventor RUIZ, JUAN A.MAYNARD, JAMES R.
Owner RUIZ JUAN A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com